|
CRCAH Project No: #CD192
|
|
Administering Organisation: The University
of Melbourne
Project Leader:
Margaret Heffernan, OAM
Program Manager: Arwen
Pratt,
Chronic
Conditions Program
Partners Involved:
- The University of Melbourne
- Victorian Aboriginal Community Controlled Health Organisation
(VACCHO)
- PapScreen Victoria
- Northern Territory Department of Health and Community Services
(NTDHCS)
- Division of General Practice (Vic.)
- Chinese Women’s Association (Box Hill, Vic.)
- Victorian Cytology Service
- Royal Women’s Hospital, Melbourne
- Royal Children’s Hospital, Melbourne
- CRC for Aboriginal Health
|
|
Project Summary:
The aim of the project was to identify issues among parents and
guardians from three cultures in Australia, as well as General
Practitioners (GPs) in Victoria and Aboriginal Health Workers
(AHWs) in Central Australia and Victoria, towards the HPV vaccine.
The project focused on three sample populations from Anglo, Chinese
and Aboriginal descent. The vaccine - which is highly effective
against the sexually transmitted HPV - is controversial because it
is most effective when given to girls before sexual activity
begins. It was important to understand the attitudes of consenting
parents, GPs and AHWs in order to find the best ways to educate
different communities and administer the vaccine in these
communities. This will reduce opportunities for misunderstanding
and misinterpreting the key message.
Summary of Project Outcomes:
- The participation of two Aboriginal regions in the study
resulted in high levels of vaccine uptake and empowered health
professional, particularly AHWs, working in the regions. As a
result, AHWs were able to educate their communities appropriately
at the time of HPV vaccine mass immunisation.
- The research found that the education resources developed for
the Northern Territory were not appropriate culturally
linguistically for the Central Australian population. As a direct
result of this finding, the NTDHCS committed funding to develop
resources in five languages common to the Central Australian
region, which will be driven by the study’s Aboriginal
Advisory and Field Supervisors.
- Resources for the Victorian Aboriginal population were also
developed concurrently by Victorian Aboriginal Study Advisor, Peta
Reynolds. The material supported the AHWs in Central Australia who
used the fact sheet for community education.
Timelines:
The project commenced in late 2004, when the HPV vaccine was at
late stage 3 trials with an expectation that licensure and public
availability to Australian communities would occur in 2008. The
data collection and analysis was completed in 2007 with the final
report due mid-2008.
Project Publications:
Related Links:
Establishing the
prevalence of the Human Papilomavirus infection in Indigenous and
non-Indigenous women in Australia (Project Leader: Suzanne
Garland)
Back to research
projects
[Page last updated April 2008]